BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morrow D, Ussi A, Migliaccio G. Addressing Pressing Needs in the Development of Advanced Therapies. Front Bioeng Biotechnol 2017;5:55. [PMID: 28993805 DOI: 10.3389/fbioe.2017.00055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Bak A, Friis KP, Wu Y, Ho RJ. Translating Cell and Gene Biopharmaceutical Products for Health and Market Impact. Product Scaling From Clinical to Marketplace: Lessons Learned and Future Outlook. Journal of Pharmaceutical Sciences 2019;108:3169-75. [DOI: 10.1016/j.xphs.2019.05.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ferreira H, Fangueiro JF, Neves NM. The Role of Natural-Based Biomaterials in Advanced Therapies for Autoimmune Diseases. In: Chun HJ, Park K, Kim C, Khang G, editors. Novel Biomaterials for Regenerative Medicine. Singapore: Springer; 2018. pp. 127-46. [DOI: 10.1007/978-981-13-0947-2_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Garcia-Aponte OF, Herwig C, Kozma B. Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy. J Biol Eng 2021;15:13. [PMID: 33849630 DOI: 10.1186/s13036-021-00264-7] [Reference Citation Analysis]
4 Faulkner E, Spinner DS, Ringo M, Carroll M. Are Global Health Systems Ready for Transformative Therapies? Value in Health 2019;22:627-41. [DOI: 10.1016/j.jval.2019.04.1911] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
5 Coppens DG, Gardarsdottir H, van den Bogert CA, De Bruin ML, Leufkens HG, Hoekman J. Publication rates and reported results in a cohort of gene- and cell-based therapy trials. Regen Med 2020;15:1215-27. [PMID: 32103712 DOI: 10.2217/rme-2019-0066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Scavone C, di Mauro G, Mascolo A, Berrino L, Rossi F, Capuano A. The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. Front Pharmacol 2019;10:111. [PMID: 30814951 DOI: 10.3389/fphar.2019.00111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
7 Ten Ham RMT, Hoekman J, Hövels AM, Broekmans AW, Leufkens HGM, Klungel OH. Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe. Mol Ther Methods Clin Dev 2018;11:121-30. [PMID: 30456217 DOI: 10.1016/j.omtm.2018.10.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
8 Moutsatsou P, Ochs J, Schmitt RH, Hewitt CJ, Hanga MP. Automation in cell and gene therapy manufacturing: from past to future. Biotechnol Lett 2019;41:1245-53. [PMID: 31541330 DOI: 10.1007/s10529-019-02732-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
9 Coppens DGM, Hoekman J, De Bruin ML, Slaper-Cortenbach ICM, Leufkens HGM, Meij P, Gardarsdottir H. Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries. Cytotherapy 2020;22:592-600. [PMID: 32563611 DOI: 10.1016/j.jcyt.2020.04.092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Post MJ, Levenberg S, Kaplan DL, Genovese N, Fu J, Bryant CJ, Negowetti N, Verzijden K, Moutsatsou P. Scientific, sustainability and regulatory challenges of cultured meat. Nat Food 2020;1:403-15. [DOI: 10.1038/s43016-020-0112-z] [Cited by in Crossref: 42] [Cited by in F6Publishing: 12] [Article Influence: 42.0] [Reference Citation Analysis]
11 Doulgkeroglou MN, Di Nubila A, Niessing B, König N, Schmitt RH, Damen J, Szilvassy SJ, Chang W, Csontos L, Louis S, Kugelmeier P, Ronfard V, Bayon Y, Zeugolis DI. Automation, Monitoring, and Standardization of Cell Product Manufacturing. Front Bioeng Biotechnol 2020;8:811. [PMID: 32766229 DOI: 10.3389/fbioe.2020.00811] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
12 ten Ham RM, Hövels AM, Klungel OH, Leufkens HG, Broekmans AW, Hoekman J. Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection. Trends in Pharmacological Sciences 2020;41:67-71. [DOI: 10.1016/j.tips.2019.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]